New Jersey Startup Launches With Clinical Assets From Big Name Biotechs Post author:Sam Post published:August 21, 2017 Post category:BioPharma August 22, 2017By Mark Terry<… Source: BioSpace You Might Also Like How Much Cash Kite Pharma's Execs Made From Its $12 Billion Gilead Deal September 28, 2017 Pfizer Terminates PDC Agreement with CytomX Therapeutics March 7, 2018 Allergan Swoops in and Bags Troubled Repros Therapeutics December 11, 2017
